COVID-19-related encephalopathy responsive to high-dose glucocorticoids

58Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.
Get full text

Abstract

One hundred twenty patients with coronavirus disease 2019 (COVID-19) were hospitalized in our intensive care unit, Geneva, Switzerland, between March 9 and April 16, 2020. We report the clinical evolution of 5 consecutive patients intubated because of COVID-19-related acute respiratory distress syndrome, presenting with a pathologic recovery of consciousness, which was responsive to high-dose glucocorticoids. These patients all presented with angio-MRI signs of inflammation of CNS arteries, consistent with an endothelialitis rather than a vasculitis. The median time between COVID-19 first symptoms and intubation was 10 days (IQR 10-11 days).

Cite

CITATION STYLE

APA

Pugin, D., Vargas, M. I., Thieffry, C., Schibler, M., Grosgurin, O., Pugin, J., & Lalive, P. H. (2020). COVID-19-related encephalopathy responsive to high-dose glucocorticoids. Neurology, 95(12), 543–546. https://doi.org/10.1212/WNL.0000000000010354

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free